Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment

BACKGROUND: Aromatase inhibitor (AI)-induced joint pain is a common toxicity of AI treatment. Although many studies have been conducted to examine the occurrence and severity of AI-induced joint pain in breast cancer survivors, none of the studies focused on the Chinese population with breast cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Huang, Yu-Yan, Liu, Xian-Liang, Molassiotis, Alex, Yao, Li-Qun, Zheng, Si-Lin, Tan, Jing-Yu (Benjamin), Huang, Hou-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633515/
https://www.ncbi.nlm.nih.gov/pubmed/36065027
http://dx.doi.org/10.1007/s00520-022-07345-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9633515/
https://www.ncbi.nlm.nih.gov/pubmed/36065027
http://dx.doi.org/10.1007/s00520-022-07345-3

Ejemplares similares